Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABT-639 electrophysiology study in painful diabetic peripheral neuropathy
2011-005127-40Phase 2Completed
- Sponsor
- Abbott Laboratories
- Start
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ABT-639 in diabetic polyneuropathy (DPN), diabetic neuropathy, sponsored by Abbott Laboratories. Started Feb 2012; status: completed.
02
Drugs
ABT-639
03
Conditions
diabetic polyneuropathy (DPN)diabetic neuropathy
Beyond the preview
Go deeper on 2011-005127-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005127-40.